Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 10, 2026, 4:08 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2065–2088 of 2,478 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Tissue Control Group Clear all

Conditions: Osteoarthritis of the Knee
Interventions: Amniotic Fluid 4.0ml dose, Amniotic Fluid 2.0ml dose, Placebo Control; Other
Lead sponsor: MiMedx Group, Inc.; Industry
Eligibility: 30 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 2
States / cities: Birmingham, Alabama • Des Plaines, Illinois

Conditions: Head and Neck Neoplasms
Interventions: Software Solution for Radiation Therapy Treatment, Radiation therapy; Other
Lead sponsor: The University of Texas Health Science Center at San Antonio; Other
Eligibility: 18 Years and older
Enrollment: 21 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: San Antonio, Texas

Conditions: Neonatal Abstinence Syndrome
Interventions: Clonidine HCL, saline; Drug
Lead sponsor: Johns Hopkins University; Other
Eligibility: 5 Days to 90 Days
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2014
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Pain
Interventions: Magnesium, Normal saline; Drug
Lead sponsor: Ann & Robert H Lurie Children's Hospital of Chicago; Other
Eligibility: 4 Years to 10 Years
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Respiratory Distress Syndrome, Newborn
Interventions: Fluid Management Intervention; Other
Lead sponsor: University of Oklahoma; Other
Eligibility: Up to 12 Hours
Enrollment: 65 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2021
U.S. locations: 2
States / cities: New York, New York • Lawton, Oklahoma

Conditions: Ischemic Stroke, Stroke, Acute
Interventions: Tenecteplase, Control; Drug · Other
Lead sponsor: University Hospital of North Norway; Other
Eligibility: 18 Years and older
Enrollment: 600 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2022
U.S. locations: 1
States / cities: Worcester, Massachusetts

Conditions: Lumbar Puncture, Topical Analgesia
Interventions: J-Tip, EMLA, Lidocaine; Device · Drug
Lead sponsor: University of Colorado, Denver; Other
Eligibility: Up to 18 Years
Enrollment: 66 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2016
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Endometriosis, Infertility
Interventions: Leuprolide acetate in depot suspension, No intervention; Drug · Other
Lead sponsor: Colorado Center for Reproductive Medicine; Other
Eligibility: 21 Years to 42 Years · Female only
Enrollment: 37 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2010
U.S. locations: 1
States / cities: Lone Tree, Colorado

Conditions: Persistent Post Operative Opioid Use, Post-surgical Pain
Interventions: PGx guided personalized post-operative pain management, Oxycodone, Hydromorphone; Other · Drug
Lead sponsor: University of Tennessee Graduate School of Medicine; Other
Eligibility: 18 Years to 85 Years
Enrollment: 208 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Knoxville, Tennessee

Conditions: Cutibacterium Acnes
Interventions: No Alexis orthopaedic protector, Alexis orthopaedic protector; Other · Device
Lead sponsor: University of Utah; Other
Eligibility: 40 Years to 90 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Crohn's Disease
Interventions: Fecal Microbial transplant, Normal Saline, rifaximin+omeprazole+miralax; Biological · Drug
Lead sponsor: Seattle Children's Hospital; Other
Eligibility: 12 Years to 21 Years
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Endothelial Dysfunction, Metabolic Syndrome, Chronic Inflammation
Interventions: UCMSCs, BMMSCs, Placebo; Biological · Other
Lead sponsor: Joshua M Hare; Other
Eligibility: 21 Years to 95 Years
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2021
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Post-operative Pain, Cesarean Section
Interventions: ON-Q Pump® with continuous infusion of bupivacaine, ON-Q Pump® with continuous infusion of saline; Device
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2027
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Glaucoma
Interventions: Prostaglandin Analogue -Containing IOP-Lowering Therapy, Beta Blocker, Brillouin Microscopy; Drug · Device
Lead sponsor: University of Maryland, Baltimore; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Osteoarthritis, Hip
Interventions: FX006, Normal saline; Drug
Lead sponsor: Pacira Pharmaceuticals, Inc; Industry
Eligibility: 40 Years to 80 Years
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 32
States / cities: Phoenix, Arizona • Tucson, Arizona • Canoga Park, California + 27 more

Conditions: Cancer
Interventions: aprepitant, dexamethasone, ondansetron, placebo; Drug
Lead sponsor: OHSU Knight Cancer Institute; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2009
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Necrotizing Soft Tissue Infection, Sepsis
Interventions: HAT, Placebo; Drug
Lead sponsor: Ascension Health; Industry
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Wichita, Kansas

Conditions: Chemotherapy-induced Nausea and Vomiting
Interventions: Standard of Care Treatment for Chemotherapy Induced Nausea and Vomiting (CINV), Aromatherapy Care; Drug
Lead sponsor: University of Miami; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Osteoarthritis
Interventions: OrthoSensor Verasense Technology; Device
Lead sponsor: Hospital for Special Surgery, New York; Other
Eligibility: 40 Years to 100 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: New York, New York

Conditions: COVID-19, Diabete Mellitus
Interventions: Measure of physiologic parameters; Other
Lead sponsor: The University of Texas Health Science Center at San Antonio; Other
Eligibility: 18 Years to 75 Years
Enrollment: 23 participants
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: San Antonio, Texas

Conditions: Peripheral Vascular Disease
Interventions: Cryoplasty (PolarCath peripheral balloon catheter), Laser Angioplasty (Spectranetics), SilverHawk Atherectomy, Viabahn Endograft, Angioplasty/Stent (Guidant "Absolute" stent); Procedure · Device
Lead sponsor: Arizona Heart Institute; Other
Eligibility: 18 Years and older
Enrollment: 130 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2009
U.S. locations: 1
States / cities: Phoenix, Arizona

Conditions: Body Fat
Interventions: Cutera truSculpt; Device
Lead sponsor: Cutera Inc.; Industry
Eligibility: 24 Years to 60 Years
Enrollment: 12 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Brisbane, California

Conditions: Depression, Healthy, Osteopenia, Osteoporosis
Interventions: Alendronate; Drug
Lead sponsor: National Institute of Mental Health (NIMH); NIH
Eligibility: 21 Years to 45 Years · Female only
Enrollment: 220 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2000 – 2007
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Hemostasis
Interventions: Fibrin Pad, SURGICEL™; Drug · Device
Lead sponsor: Ethicon, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 141 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2009
U.S. locations: 11
States / cities: Birmingham, Alabama • Jacksonville, Florida • Miami, Florida + 6 more

Search by objective public record fields.

Evaluation of Amniotic Fluid Product in Knee Osteoarthritis

Radiation Therapy Plan Quality Improvement Using Ideal Theoretical Isodose Distribution

Clonidine to Treat Iatrogenic-induced Opioid Dependence in Infants

Magnesium vs Placebo for Tonsillectomy

Fluid Restriction in Respiratory Distress of the Newborn

Tenecteplase in Wake-up Ischaemic Stroke Trial

Jet Injection of 1% Buffered Lidocaine Versus Topical EMLA for Local Anesthesia Before Lumbar Puncture in Children

Endometrial Markers and Response of Endometriosis Patients to Prolonged GnRH Agonist Prior to IVF

Personalized Post-Operative Pain Management

Do Wound Protectors Reduce Contamination in Total Shoulder Arthroplasty?

Fecal Microbial Transplant in Pediatric Crohn's Disease

Infusion of Umbilical Cord Versus Bone Marrow Derived Mesenchymal Stem Cells to Evaluate Cytokine Suppression.

Post-operative Cesarean Trial of Pain Control

Study of Corneal Biomechanics in Glaucoma Patients Using Brillouin Microscopy

Study to Evaluate the Efficacy and Safety of FX006 in Patients With Hip Osteoarthritis

Aprepitant in Preventing Nausea and Vomiting in Patients Who Are Undergoing a Stem Cell Transplant

HAT for the Treatment of Sepsis Associated With NASTI

Aromatherapy for Chemotherapy-induced Nausea and Vomiting (CINV)

TKR With and Without the Use of Intra-operative Sensing

Long-Term Sequelae of SARS-COV-2 Infection: Diabetes Mellitus

Prime Time for Superficial Femoral Artery (SFA) - The SFA Study

Performance Evaluation of the truSculpt Radiofrequency Device for Lipolysis of Abdominal Fat

Bone Loss in Premenopausal Women With Depression

The Fibrin Patch Soft Tissue Study